EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT

Betül Çelik iD, İrem Peker Eyüboğlu iD, Sinan Koca iD, M Ümit Uğurlu iD, Özkan Alan iD, Gökçe Güllü Amuran iD, Tuğba Akin Telli iD, Fulden Yumuk iD, Mustafa Akkiprik iD

Turkish Journal of Medical Sciences · 23.08.2024 · 54 (4) · 652-665

DOI: 10.55730/1300-0144.5834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 23.08.2024. Verfasst von Betül Çelik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology and Genetics, Health Sciences Institute, Marmara University, İstanbul, Turkiye. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA, Mitochondrial, Epithelial-Mesenchymal Transition, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Breast cancer is the most prevalent cancer in women, emphasizing need for noninvasive blood biomarkers to aid in treatment selection. Previous studies have demonstrated elevated levels of plasma circulating cell-free DNA (ccfDNA) in breast cancer patients. Both ccfDNA and mitochondrial DNA (mtDNA) are fragments released into the bloodstream. In this study, we investigated effectiveness of ccfDNA and mtDNA as indicators of treatment response and explored their potential as monitoring biomarkers. Additionally, we compared these markers with circulating tumor cell (CTC) data and assessed their relationship with epithelial-mesenchymal transition (EMT).Materials and methods: Thirty-six female breast cancer patients and 21 healthy females were included in the study. Quantitative polymerase chain reaction (qPCR) was performed on plasma samples to measure levels of ND1, ND4, ALU115, ALU247, and GAPDH, and DNA integrity was determined by calculating ratios of ALU247/ALU115 and ND4/ND1.

Results

After treatment, patients had a significant decrease in ccfDNA levels and a significant increase in mtDNA copy number (mtDNAcn). However, there was no significant change in ccfDNA and mtDNA integrity. When comparing all groups, patients exhibited higher levels of ALU115 and ALU247 compared to controls. Moreover, patients demonstrated significantly lower ccfDNA integrity than controls.

Conclusion

This study represents the first comprehensive investigation of plasma ccfDNA levels, mtDNAcn, and integrities collectively. Furthermore, it is the first study to explore the relationship between these markers and CTCs, cancer stem cell markers, treatment response, and metastatic status. Our findings suggest that plasma ccfDNA and mtDNA may serve as potential biomarkers for assessing chemotherapy response and can be employed alone or in combination with other biomarkers to monitor treatment efficacy in breast cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDNA, MitochondrialEpithelial-Mesenchymal TransitionNeoplastic Cells, CirculatingCell-Free Nucleic AcidsBiomarkers, TumorHumansFemaleMiddle AgedAdultNeoadjuvant TherapyAged

Stichwörter der Autor:innen

Breast cancerEMTccfDNAmtDNAneoadjuvant therapy

Substanzen

DNA, MitochondrialCell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Biology and Genetics, Health Sciences Institute, Marmara University, İstanbul, Turkiye.
  • Department of Medical Biology, School of Medicine, Marmara University, İstanbul, Turkiye.
  • Department of Medical Oncology, Ümraniye Education Research Hospital, İstanbul, Turkiye.
  • Department of General Surgery, School of Medicine, Marmara University, İstanbul, Turkiye.
  • Department of Medical Oncology, School of Medicine, Marmara University, İstanbul, Turkiye.

ORCID-Profile: Betül Çelik, İrem Peker Eyüboğlu, Sinan Koca, M Ümit Uğurlu, Özkan Alan, Gökçe Güllü Amuran, Tuğba Akin Telli, Fulden Yumuk, Mustafa Akkiprik

Zitieren

APA

Çelik, B., Peker Eyüboğlu, İ., Koca, S., Uğurlu, M. Ü., Alan, Ö., Güllü Amuran, G., Akin Telli, T., Yumuk, F., & Akkiprik, M. (2024). Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT. Turkish Journal of Medical Sciences, 54(4), 652-665. https://doi.org/10.55730/1300-0144.5834

Vancouver

Çelik B, Peker Eyüboğlu İ, Koca S, Uğurlu MÜ, Alan Ö, Güllü Amuran G, et al. Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT. Turkish Journal of Medical Sciences. 2024;54(4):652-665. doi:10.55730/1300-0144.5834

BibTeX
@article{elik2024,
  author = {Çelik, Betül and Peker Eyüboğlu, İrem and Koca, Sinan and Uğurlu, M Ümit and Alan, Özkan and Güllü Amuran, Gökçe and Akin Telli, Tuğba and Yumuk, Fulden and Akkiprik, Mustafa},
  title = {Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {4},
  pages = {652--665},
  doi = {10.55730/1300-0144.5834}
}
Kostenlos starten →